HY-N0316-10mg
|
MedChemexpress LLC
|
Mollugin [CAS 55481-88-4]
|
|
Cancer-programmed cell death
|
|
HY-N0316-20mg
|
MedChemexpress LLC
|
Mollugin [CAS 55481-88-4]
|
|
Cancer-programmed cell death
|
|
HY-N0316-5mg
|
MedChemexpress LLC
|
Mollugin [CAS 55481-88-4]
|
|
Cancer-programmed cell death
|
|
HY-N0750-100mg
|
MedChemexpress LLC
|
Monocrotaline [CAS 315-22-0]
|
|
Cancer-programmed cell death
|
|
HY-N0750-200mg
|
MedChemexpress LLC
|
Monocrotaline [CAS 315-22-0]
|
|
Cancer-programmed cell death
|
|
HY-N0750-50mg
|
MedChemexpress LLC
|
Monocrotaline [CAS 315-22-0]
|
|
Cancer-programmed cell death
|
|
HY-N0750-500mg
|
MedChemexpress LLC
|
Monocrotaline [CAS 315-22-0]
|
|
Cancer-programmed cell death
|
|
HY-N0750-1mL
|
MedChemexpress LLC
|
Monocrotaline [CAS 315-22-0] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-N3245-10mg
|
MedChemexpress LLC
|
Moracin C [CAS 69120-06-5]
|
|
COVID-19-immunoregulation
|
|
HY-N3245-5mg
|
MedChemexpress LLC
|
Moracin C [CAS 69120-06-5]
|
|
COVID-19-immunoregulation
|
|
HY-P99033-1mg
|
MedChemexpress LLC
|
Mosunetuzumab [CAS 1905409-39-3]
|
|
COVID-19-immunoregulation
|
|
HY-P99033-5mg
|
MedChemexpress LLC
|
Mosunetuzumab [CAS 1905409-39-3]
|
|
COVID-19-immunoregulation
|
|